Riva N et al. |
Survival Time to Biopsy-Proven Acute Rejection and Tacrolimus Adverse Drug Reactions in Pediatric Liver Transplantation. |
2018 |
Ther Drug Monit |
pmid:29621122
|
Choi CB et al. |
Outcomes of multitarget therapy using mycophenolate mofetil and tacrolimus for refractory or relapsing lupus nephritis. |
2018 |
Lupus |
pmid:29448881
|
Charlton M et al. |
Everolimus Is Associated With Less Weight Gain Than Tacrolimus 2 Years After Liver Transplantation: Results of a Randomized Multicenter Study. |
2017 |
Transplantation |
pmid:28817434
|
Kumai Y et al. |
Reversible Cerebral Vasoconstriction Syndrome After Heart Transplantation: A Case Report. |
2017 |
Transplant. Proc. |
pmid:29198694
|
Savić V et al. |
Tacrolimus loaded biocompatible lecithin-based microemulsions with improved skin penetration: Structure characterization and in vitro/in vivo performances. |
2017 |
Int J Pharm |
pmid:28711641
|
Groll AH et al. |
Pharmacokinetic Assessment of Drug-Drug Interactions of Isavuconazole With the Immunosuppressants Cyclosporine, Mycophenolic Acid, Prednisolone, Sirolimus, and Tacrolimus in Healthy Adults. |
2017 |
Clin Pharmacol Drug Dev |
pmid:27273343
|
BenÃtez C et al. |
Letter: sublingual dosing of tacrolimus in transplant patients-interesting concept to overcome first pass effects. Authors' reply. |
2017 |
Aliment. Pharmacol. Ther. |
pmid:28589580
|
Kodama S et al. |
Tacrolimus-Induced Reversible Cerebral Vasoconstriction Syndrome with Delayed Multi-Segmental Vasoconstriction. |
2017 |
J Stroke Cerebrovasc Dis |
pmid:28342655
|
Wang J et al. |
Metabolic network model guided engineering ethylmalonyl-CoA pathway to improve ascomycin production in Streptomyces hygroscopicus var. ascomyceticus. |
2017 |
Microb. Cell Fact. |
pmid:28974216
|
Cohen JB et al. |
Belatacept Compared With Tacrolimus for Kidney Transplantation: A Propensity Score Matched Cohort Study. |
2017 |
Transplantation |
pmid:27941427
|